Resource hub · Free

Pharmacy & medical glossary

150 plain-language definitions of pharmacy reimbursement, PBM, Medicare Part D, clinical, compliance, and operations terms.

[ 150 of 150 terms ]

#

340B Drug Pricing Program

A federal program requiring manufacturers to sell outpatient drugs at steep discounts to eligible safety-net providers, which often dispense through contracted retail pharmacies.

Regulatory & compliance

503A Pharmacy

A compounding pharmacy that prepares patient-specific compounded drugs under a prescription, regulated mainly by state boards of pharmacy.

Regulatory & compliance

503B Outsourcing Facility

A facility that compounds sterile drugs in larger quantities, with or without patient-specific prescriptions, registered with and inspected by the FDA under current good manufacturing practice.

Regulatory & compliance

A

AAC (Actual Acquisition Cost)

The price a pharmacy actually pays for a drug after discounts. Many state Medicaid programs base ingredient-cost reimbursement on an estimate of AAC, often using NADAC.

Reimbursement & pricing

Accreditation

Third-party validation of a pharmacy's quality and processes, such as from URAC, ACHC, or the Joint Commission. Often required for specialty and payer network access.

Regulatory & compliance

ACE Inhibitor

Angiotensin-converting enzyme inhibitor; a drug class used mainly for high blood pressure and heart failure, such as lisinopril.

Clinical & dispensing

Acquisition Cost

What a pharmacy pays its wholesaler or supplier for a drug, net of invoice discounts. Comparing acquisition cost to reimbursement shows the margin on each claim.

Reimbursement & pricing

Adherence

How closely a patient takes medications as prescribed. Adherence affects health outcomes and, in Medicare, plan Star Ratings.

Clinical & dispensing

Adverse Drug Reaction

A harmful or unintended response to a medication at a normal dose.

Clinical & dispensing

AMP (Average Manufacturer Price)

The average price wholesalers and certain pharmacies pay manufacturers for a drug. AMP is reported to CMS and used to calculate Medicaid drug rebates and Federal Upper Limits.

Reimbursement & pricing

Annual Enrollment Period (AEP)

Medicare's open enrollment, October 15 to December 7 each year, when beneficiaries can switch Part D and Medicare Advantage plans for the next January.

Anticoagulant

A blood thinner that prevents or reduces blood clotting, such as apixaban or warfarin.

Clinical & dispensing

Any Willing Pharmacy

Laws or contract terms requiring a plan or PBM to let any pharmacy join its network if the pharmacy accepts the network's terms.

PBMs & plans

ASP (Average Sales Price)

A manufacturer-reported price net of most discounts, used by Medicare to pay for most Part B drugs (generally ASP plus 6%).

Reimbursement & pricing

AWP (Average Wholesale Price)

A published list-price benchmark for drugs. Despite the name, it is not what pharmacies pay; contracts often reimburse brand drugs as AWP minus a percentage.

Reimbursement & pricing

B

Base Beneficiary Premium

A figure CMS sets each year to calculate Part D premiums and the late-enrollment penalty. It is $41.33 for 2027, up from $38.99 in 2026.

BER (Brand Effective Rate)

A guaranteed average discount off AWP across all brand claims in a contract period. If actual reimbursement beats the guarantee, the PBM may claw back the difference at reconciliation.

Reimbursement & pricing

BIN, PCN, and Group Number

Identifiers on a prescription card that route a pharmacy claim: the BIN identifies the processor, the PCN identifies the benefit, and the group number identifies the employer or plan.

PBMs & plans

Bioavailability

The share of a dose that reaches the bloodstream and can have an effect.

Clinical & dispensing

Bioequivalent

Two drug products that deliver the same active ingredient at a rate and extent of absorption without a significant difference. Bioequivalence is the basis for generic approval.

Clinical & dispensing

Biologic

A medicine made from living cells, such as insulin, monoclonal antibodies, or vaccines. Biologics are usually more complex and costly than small-molecule drugs.

Clinical & dispensing

Biosimilar

A biologic that is highly similar to an FDA-approved reference biologic with no clinically meaningful differences in safety or effectiveness.

Clinical & dispensing

Black Box Warning

The FDA's strongest label warning, used when a drug carries a serious or life-threatening risk.

Clinical & dispensing

Board of Pharmacy

The state agency that licenses pharmacies and pharmacists and enforces state pharmacy law.

Regulatory & compliance

Brand-Name Drug

A drug sold under a trademarked name by the company that developed it, often under patent protection.

Clinical & dispensing

C

Carve-Out

When an employer or health plan contracts its pharmacy benefit separately from its medical benefit, often with a standalone PBM.

PBMs & plans

Catastrophic Phase

The final Part D coverage phase. Once a beneficiary's out-of-pocket costs reach the annual cap, they pay nothing more for covered Part D drugs that year.

Medicare & Medicaid

Central Fill

A model where prescriptions are filled at a central automated facility and delivered to a pharmacy or patient, freeing store staff for patient care.

Operations & technology

Claim Reversal

Canceling a previously submitted pharmacy claim, for example when a prescription is not picked up within the allowed return-to-stock window.

Operations & technology

Clawback

Money a PBM or plan takes back from a pharmacy after a claim is paid, for example through effective-rate reconciliation, audit recoupment, or a patient copay that exceeds the drug's reimbursed cost.

Reimbursement & pricingEnterprise pharmacy consulting

Clinical Pharmacy

Pharmacy practice focused on direct patient care: optimizing medication use and promoting health and disease prevention.

Clinical & dispensing

Closed-Door Pharmacy

A pharmacy that does not serve walk-in customers, such as long-term care, mail-order, or some specialty pharmacies.

Operations & technology

CMS (Centers for Medicare & Medicaid Services)

The federal agency that runs Medicare, works with states on Medicaid, and publishes Part D plan, pricing, and quality data.

Medicare & Medicaid

Coinsurance

A patient's share of a drug's cost expressed as a percentage, such as 25%, rather than a fixed dollar copay.

PBMs & plans

Collaborative Practice Agreement

A formal agreement that lets a pharmacist perform certain patient care functions, such as adjusting doses or initiating therapy, under a protocol with a prescriber. Scope varies by state.

Clinical & dispensing

Compounding

Preparing a customized medication by combining or altering ingredients to meet a specific patient's needs, such as a different strength or dosage form.

Clinical & dispensing

Comprehensive Medication Review (CMR)

An interactive review of all of a patient's medications by a pharmacist or other qualified provider, required as part of Part D Medication Therapy Management programs.

Medicare & Medicaid

Controlled Substance

A drug regulated by the DEA because of its potential for abuse or dependence, classified into Schedules I through V.

Regulatory & compliance

Copay Accumulator

A plan design in which manufacturer copay assistance does not count toward a patient's deductible or out-of-pocket maximum.

PBMs & plans

Copay Maximizer

A plan design that spreads the full value of manufacturer copay assistance across the plan year, typically by raising the patient's cost share for specialty drugs.

PBMs & plans

Copayment

A fixed dollar amount a patient pays for a covered prescription, such as $10 for a generic. The plan pays the rest of the agreed price to the pharmacy.

PBMs & plans

Cost-Plus Pricing

A transparent pricing model where the drug price is the acquisition cost plus a set markup and dispensing fee, rather than a discount off a list-price benchmark.

Reimbursement & pricing

Coverage Gap (Donut Hole)

A former Part D phase where patients paid a larger share of drug costs. The Inflation Reduction Act eliminated it starting in 2025.

Medicare & Medicaid

D

DAW Code (Dispense as Written)

A code on a claim (0 to 9) that tells the payer why a brand or generic was dispensed, for example DAW 1 when the prescriber requires the brand.

Clinical & dispensing

Days Supply

How many days a dispensed quantity should last at the prescribed dose. Plans use days supply to apply refill timing and quantity limits.

Clinical & dispensing

DEA Form 222

The DEA order form, paper or electronic (CSOS), required to order Schedule I and II controlled substances.

Regulatory & compliance

DEA Number

A registration number the Drug Enforcement Administration assigns to prescribers and pharmacies that handle controlled substances.

Regulatory & compliance

Deductible

The amount a patient pays for covered drugs each year before the plan starts sharing costs.

PBMs & plans

Delinking

Separating PBM compensation from drug list prices and rebates, typically by paying PBMs a flat service fee. Federal law requires delinking in Medicare Part D starting in 2028.

DIR Fees

Direct and Indirect Remuneration: price concessions PBMs historically collected from pharmacies months after a Part D claim was paid. Since January 1, 2024, pharmacy price concessions in Part D must be reflected at the point of sale.

Dispensing Fee

The fee paid to a pharmacy, on top of ingredient cost, for the professional service and overhead of filling a prescription.

Reimbursement & pricing

Drug-Drug Interaction

A change in a drug's effect when taken with another drug, which may increase side effects or reduce effectiveness.

Clinical & dispensing

DSCSA (Drug Supply Chain Security Act)

A federal law requiring electronic, interoperable tracing of prescription drug packages through the supply chain to identify and remove counterfeit or illegitimate products.

Regulatory & compliance

Dual Eligible

A person enrolled in both Medicare and Medicaid. Dual eligibles receive Extra Help with Part D costs automatically.

Medicare & Medicaid

E

E-Prescribing

Electronic transmission of a prescription from the prescriber to the pharmacy, typically using the NCPDP SCRIPT standard.

Operations & technology

Effective Rate

A contractual guarantee that a pharmacy's average reimbursement across a group of claims will equal a set discount off a benchmark such as AWP. Shortfalls or overages are settled at reconciliation.

Reimbursement & pricing

Electronic Health Record (EHR)

A digital record of a patient's health information used by providers. Pharmacies increasingly exchange data with EHRs for prescriptions, immunizations, and care coordination.

Operations & technologyCustom pharmacy applications

ePA (Electronic Prior Authorization)

Completing prior authorization requests electronically within prescriber and pharmacy systems, reducing fax and phone delays.

Operations & technology

EPCS (Electronic Prescribing of Controlled Substances)

Electronic transmission of controlled-substance prescriptions with identity proofing and two-factor authentication. Required for Medicare Part D controlled-substance prescriptions.

Regulatory & compliance

ERISA

The Employee Retirement Income Security Act, the federal law governing most private employer benefit plans. ERISA fiduciary duties apply to how self-funded employers manage pharmacy benefits.

Extra Help (Low-Income Subsidy, LIS)

A Medicare program that lowers Part D premiums, deductibles, and copays for people with limited income and resources.

Medicare & Medicaid

F

FDA (Food and Drug Administration)

The federal agency that approves drugs and biologics and regulates their safety, effectiveness, manufacturing, and labeling.

Regulatory & compliance

FHIR

Fast Healthcare Interoperability Resources, a modern HL7 standard for exchanging healthcare data through APIs.

Operations & technologyCustom pharmacy applications

Formulary

A plan's list of covered drugs, usually organized into tiers that set the patient's cost sharing.

PBMs & plans

Formulary Exception

A request asking a plan to cover a non-formulary drug or to lower its cost-sharing tier, usually supported by the prescriber's statement of medical need.

PBMs & plans

FUL (Federal Upper Limit)

A cap on what Medicaid will reimburse for many multiple-source generic drugs, generally set at 175% of the weighted average AMP.

Reimbursement & pricing

FWA (Fraud, Waste, and Abuse)

Improper payments and practices that Medicare and Medicaid programs work to prevent. Part D network pharmacies are expected to have FWA compliance programs.

Regulatory & compliance

G

Generic Drug

A medication equivalent to a brand-name drug in active ingredient, strength, dosage form, route, and performance, typically sold at a much lower price.

Clinical & dispensing

Generic Substitution

Dispensing an FDA-rated therapeutically equivalent generic in place of the prescribed brand, as permitted by state law.

Clinical & dispensing

GER (Generic Effective Rate)

A guaranteed average discount off AWP across all generic claims in a contract period. Because generic AWPs vary widely, GER contracts can produce large year-end clawbacks.

Reimbursement & pricing

GLP-1 Receptor Agonist

A drug class used for type 2 diabetes and, for some products, weight management, such as semaglutide and tirzepatide. GLP-1s are among the highest-spend drugs in pharmacy benefits.

GPO (Group Purchasing Organization)

An organization that uses the combined buying power of its members to negotiate discounts from wholesalers and manufacturers.

Operations & technology

H

HIPAA

The Health Insurance Portability and Accountability Act, which sets national standards for protecting patient health information and for electronic healthcare transactions.

Regulatory & compliance

HL7

Health Level Seven, a family of standards for exchanging clinical data between healthcare systems.

Operations & technologyCustom pharmacy applications

I

In-Network Pharmacy

A pharmacy that holds a contract with a plan's pharmacy network and accepts the network's reimbursement terms.

PBMs & plans

Indication

A medical condition a drug is approved or used to treat.

Clinical & dispensing

Inflation Reduction Act (IRA)

The 2022 law that created the Medicare Drug Price Negotiation Program, redesigned the Part D benefit with an annual out-of-pocket cap, and added manufacturer inflation rebates.

Medicare & Medicaid

Ingredient Cost

The portion of a claim's reimbursement that pays for the drug itself, separate from the dispensing fee and any incentive fees.

Reimbursement & pricing

Interchangeable Biosimilar

A biosimilar the FDA has determined can be substituted for the reference product at the pharmacy without prescriber intervention, subject to state law.

Clinical & dispensing

Inventory Turns

How many times a pharmacy sells through its average inventory in a year. Higher turns mean less cash tied up in stock.

Operations & technology

L

Legend Drug

A drug that, by federal law, can be dispensed only with a prescription.

Clinical & dispensing

Long-Term Care (LTC) Pharmacy

A pharmacy serving nursing homes and assisted living facilities, typically with unit-dose packaging, frequent delivery, and consultant pharmacist services.

Operations & technology

M

MAC (Maximum Allowable Cost)

A PBM- or state-set maximum amount a plan will pay for a multiple-source drug, usually generics. MAC lists are proprietary and change frequently; pharmacies can appeal MAC prices below acquisition cost.

Reimbursement & pricing

MAC Appeal

A pharmacy's formal request that a PBM raise a MAC price that is below the pharmacy's acquisition cost. Many states set timelines and requirements for MAC appeals.

Reimbursement & pricing

Mail-Order Pharmacy

A pharmacy that dispenses and ships prescriptions, often 90-day supplies of maintenance drugs. Many large PBMs own mail-order pharmacies.

PBMs & plans

Maximum Fair Price (MFP)

The price CMS negotiates with a manufacturer for a selected drug under the Medicare Drug Price Negotiation Program. Ten drugs took effect in 2026 and 15 more take effect in 2027.

Medicaid Managed Care

Medicaid coverage delivered through private managed care organizations under contract with a state, which often manage the pharmacy benefit through a PBM.

Medicare & Medicaid

Medicare Advantage (MA-PD)

Private plans that deliver Medicare Part A and Part B benefits, usually with Part D drug coverage included (MA-PD).

Medicare & Medicaid

Medicare Drug Price Negotiation Program

The IRA program under which CMS negotiates prices for selected high-spend Medicare drugs. Pharmacies are paid the negotiated price by plans and receive refunds from manufacturers for the difference.

Medicare Part B Drugs

Drugs covered under Medicare's medical benefit, mainly those administered in a clinic or by a provider, plus certain items dispensed by pharmacies such as some diabetic supplies and immunosuppressants.

Medicare & Medicaid

Medicare Part D

Medicare's outpatient prescription drug benefit, delivered through private stand-alone drug plans (PDPs) and Medicare Advantage drug plans (MA-PDs).

Medicare & MedicaidMedicareView

Medicare Prescription Payment Plan

A Part D option, available since 2025, that lets enrollees spread their out-of-pocket drug costs into monthly payments across the year instead of paying at the pharmacy.

Medicare & Medicaid

Medicare Transaction Facilitator (MTF)

The CMS system that shares negotiated-price claim data with manufacturers and can pass manufacturer refunds to pharmacies. Pharmacies enroll in the MTF to receive refunds.

Medication Synchronization (Med Sync)

Aligning a patient's refills so their maintenance medications can be picked up on a single day each month, improving adherence and pharmacy workflow.

Clinical & dispensing

MTM (Medication Therapy Management)

Pharmacist services that help patients get the best results from their medications. Part D plans must offer MTM programs to eligible beneficiaries.

Medicare & Medicaid

N

NADAC (National Average Drug Acquisition Cost)

A CMS benchmark, updated weekly, based on surveys of what retail community pharmacies pay for drugs. Many state Medicaid programs use NADAC to set ingredient-cost reimbursement.

Reimbursement & pricing

NCPDP

The National Council for Prescription Drug Programs, which develops the standards pharmacies use for claims (Telecommunication Standard) and e-prescribing (SCRIPT).

Operations & technology

NDC (National Drug Code)

A unique 10-digit, three-segment identifier for each drug product and package in the U.S., shown in an 11-digit format on claims.

Operations & technology

Negotiated Price (Part D)

The price a Part D plan and pharmacy agree to for a drug, including any dispensing fee. It is specific to each pharmacy, plan, and drug, and drives both the pharmacy's payment and the patient's cost sharing.

Reimbursement & pricingMedicareView

NPI (National Provider Identifier)

A unique 10-digit identifier for healthcare providers, including pharmacies, issued through CMS and used on claims.

Operations & technology

O

OIG Exclusion List

The HHS Office of Inspector General's list of individuals and entities barred from federal healthcare programs. Pharmacies screen staff against it.

Regulatory & compliance

Orange Book

The FDA's list of approved drug products with therapeutic equivalence evaluations, used to determine which generics can be substituted for a brand.

Regulatory & compliance

Orphan Drug

A drug or biologic developed to treat a rare disease or condition, which may receive special FDA incentives.

Clinical & dispensing

OTC (Over-the-Counter)

A drug that is safe and effective for use without a prescription.

Clinical & dispensing

Out-of-Pocket Maximum

The most a patient pays for covered services in a plan year. In Medicare Part D, the out-of-pocket cap is $2,100 in 2026 and $2,400 in 2027.

P

Pass-Through PBM

A PBM model in which the plan pays exactly what the pharmacy is paid, and manufacturer rebates are passed to the plan, with the PBM earning an administrative fee instead of spread.

PBM (Pharmacy Benefit Manager)

A company that manages prescription drug benefits for health plans and employers: building pharmacy networks, processing claims, setting formularies, and negotiating rebates with manufacturers.

PBMs & plans

PBM Audit

A review by a PBM of a pharmacy's claims and records. Findings can lead to recoupment of payments, so documentation and audit defense are important for pharmacies.

Regulatory & complianceEnterprise pharmacy consulting

PDC (Proportion of Days Covered)

An adherence measure: the share of days in a period a patient had medication on hand. A PDC of 80% or more is commonly treated as adherent and feeds Medicare Star Ratings.

Medicare & Medicaid

PDE (Prescription Drug Event)

The record a Part D plan submits to CMS for each paid claim, used for payment reconciliation and program oversight.

Medicare & Medicaid

PDMP (Prescription Drug Monitoring Program)

A state database of controlled-substance prescriptions that prescribers and pharmacists check to identify misuse and unsafe combinations.

Regulatory & compliance

PDP (Prescription Drug Plan)

A stand-alone Medicare Part D plan that adds drug coverage to Original Medicare. The average beneficiary has 9 PDPs to choose from in 2027, down from 11.

Pharmacogenomics

The study of how a person's genes affect their response to drugs, used to guide drug selection and dosing.

Clinical & dispensing

Pharmacokinetics

How the body absorbs, distributes, metabolizes, and eliminates a drug over time.

Clinical & dispensing

Pharmacy Management System

The core software a pharmacy uses to process prescriptions, adjudicate claims, manage inventory, and keep patient profiles. Examples include PioneerRx, Liberty, and BestRx.

Operations & technologyCustom pharmacy applications

Plan Year

The 12-month period a plan's benefits, formulary, and pricing apply to. For Medicare Part D it runs January 1 to December 31.

Medicare & Medicaid

Preferred Pharmacy Network

A subset of a plan's network where patients pay lower cost sharing, typically in exchange for lower reimbursement to the participating pharmacies.

PBMs & plans

Primary Wholesaler

The drug distributor a pharmacy buys most of its inventory from, usually under a contract with purchase-volume commitments and pricing tiers.

Operations & technology

Prior Authorization

A plan requirement that the prescriber get approval before a drug is covered, usually to confirm it meets clinical criteria.

PBMs & plans

PSAO (Pharmacy Services Administration Organization)

An organization that contracts with PBMs and payers on behalf of many independent pharmacies and provides services such as reconciliation, credentialing, and audit support.

PBMs & plans

Purple Book

The FDA's database of licensed biologics, including biosimilars and interchangeable biosimilars.

Regulatory & compliance

Q

Quality Assurance Program

A pharmacy's process for detecting, documenting, and preventing medication errors, often called continuous quality improvement (CQI) and required by many state boards.

Regulatory & compliance

Quantity Limit

A plan rule capping how much of a drug is covered over a period, such as 30 tablets per 30 days.

PBMs & plans

R

Rebate

A payment from a drug manufacturer to a PBM or plan, usually in exchange for favorable formulary placement. Rebates are paid after the sale and generally do not flow to the pharmacy.

Reimbursement & pricing

Reconciliation

Matching what a pharmacy was paid against what it was owed: claims to remittances, effective-rate guarantees to actual results, and manufacturer refunds to negotiated-price claims.

Reimbursement & pricing

Reject Code

An NCPDP code returned when a claim is denied, explaining why, such as a refill too soon or a prior authorization requirement.

Operations & technology

Remittance Advice (835)

The electronic payment explanation a pharmacy receives from a payer, detailing which claims were paid, adjusted, or recouped in each payment.

Reimbursement & pricing

REMS (Risk Evaluation and Mitigation Strategy)

An FDA-required safety program for certain drugs with serious risks, which may limit which pharmacies can dispense them or require patient monitoring.

Regulatory & compliance

Return to Stock

Reversing claims and returning unclaimed prescriptions to inventory after a set number of days, as required by most payer contracts.

Operations & technology

S

Selected Drug

A drug chosen by CMS for price negotiation under the Medicare Drug Price Negotiation Program.

Medicare & Medicaid

Self-Funded Plan

An employer health plan in which the employer pays claims directly rather than buying fully insured coverage. The employer carries the financial risk and controls pharmacy benefit design.

Sig

The directions for use on a prescription, often written in abbreviations such as "1 tab PO BID". See the sig code reference for common abbreviations.

Clinical & dispensingSig code reference

Special Enrollment Period (SEP)

A window outside annual enrollment when a Medicare beneficiary can change plans because of a qualifying event, such as moving or losing other coverage.

Medicare & Medicaid

Specialty Pharmacy

A pharmacy focused on high-cost, high-touch medications for complex or rare conditions, often with patient support, limited distribution access, and payer accreditation.

Clinical & dispensing

Specialty Tier

A formulary tier for high-cost drugs, usually with coinsurance rather than a flat copay. In Part D, drugs above a monthly cost threshold may be placed on the specialty tier.

PBMs & plans

Spread Pricing

When a PBM charges a plan sponsor more for a drug than it pays the pharmacy and keeps the difference as revenue.

Reimbursement & pricingSelf-funded plan analysis

Star Ratings

CMS's 1-to-5-star quality ratings for Medicare Advantage and Part D plans. Medication adherence measures for diabetes, cholesterol, and blood pressure drugs make pharmacies important to plan scores.

Medicare & Medicaid

Step Therapy

A plan rule requiring a patient to try a lower-cost or preferred drug before a more expensive one is covered.

PBMs & plans

Stop-Loss Insurance

Coverage a self-funded employer buys to protect against unusually large individual or total claims.

PBMs & plans

T

Therapeutic Equivalence

Drug products that are pharmaceutical equivalents and can be expected to have the same clinical effect and safety profile. The FDA publishes ratings in the Orange Book.

Clinical & dispensing

Tiered Formulary

A formulary that groups drugs into tiers, such as preferred generic, generic, preferred brand, non-preferred, and specialty, each with different patient cost sharing.

PBMs & plans

TPA (Third-Party Administrator)

A company that administers claims and plan operations for a self-funded employer without taking on insurance risk.

PBMs & plans

Transition Fill

A temporary supply of a non-formulary drug that a Part D plan must cover for new enrollees or after formulary changes, giving time to switch drugs or request an exception.

Medicare & Medicaid

Transparent PBM

A PBM that discloses its pricing, rebates, and fees to the plan sponsor, often using pass-through or cost-plus pricing.

PBMs & plans

TrOOP (True Out-of-Pocket Costs)

The Part D spending that counts toward a beneficiary's annual out-of-pocket cap, including what the patient pays and certain payments made on their behalf.

Medicare & Medicaid

U

U&C (Usual and Customary Price)

The cash price a pharmacy charges the general public for a drug. Many contracts require the pharmacy to be paid the lower of the contracted rate or its U&C.

Reimbursement & pricing

USP (United States Pharmacopeia)

A nonprofit that sets standards for medicine quality, strength, and purity, including the compounding chapters USP <795>, <797>, and <800>.

Regulatory & compliance

USP <795>, <797>, and <800>

USP standards for nonsterile compounding (<795>), sterile compounding (<797>), and handling hazardous drugs (<800>), enforced by many state boards of pharmacy.

Regulatory & compliance

Utilization Review

A review of prescriptions or services to confirm they are necessary, appropriate, and cost-effective, used by plans and PBMs.

Operations & technology

W

WAC (Wholesale Acquisition Cost)

The manufacturer's list price to wholesalers, before discounts or rebates. WAC is the default basis for Medicare negotiated-price refunds to pharmacies.

Reimbursement & pricing

Need expert consulting?

Get a free 30-minute deep dive into your pharmacy operations with our team.